Call Us Sign-Up/Sign-In
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Global Acromegaly Treatment Market Expected to Reach USD 2,299.4 Million by 2027


Global Acromegaly Tr

iCrowdNewswire   Jan 11, 2021  1:29 PM ET

17_Acromegaly Treatment Market Executive Summary

According to a recent market study published by Growth Market Reports (GMR), titled, “Global Acromegaly Treatment Market by Product, End-user, and Region: Size, Share, Trends and Opportunity Analysis, 2017-2027”, the market was valued at USD 1,304.4 Million in 2019 and is expected to grow at a healthy growth rate of 7.6% by the year 2027. The global acromegaly treatment market is anticipated to grow owing to rising prevalence of acromegaly especially in developed countries. Further, increasing awareness among the people for acromegaly, and rising number of clinical trials for acromegaly drugs are the factors which is expected to drive the growth of the global acromegaly treatment market.

Request a free sample copy: https://growthmarketreports.com/request-sample/17

The global acromegaly treatment market is fragmented based on product, end-user, and region. In terms of product, the market is segmented into somatostatin analogs, growth hormone receptor antagonist (GHRA), and dopamine agonist. On the basis of end-user, the market is divided into hospitals & clinics, and others. Based on region, the global acromegaly treatment market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, Asia Pacific is further segmented into, China, Japan, South Korea, Australia, Southeast Asia, and Rest of Asia Pacific. The Europe region is further categorized into Germany, France, Italy, U.K., Spain, Russia, and Rest of Europe, and the MEA region is further divided into Saudi Arabia, South Africa, UAE, and Rest of MEA.

Acromegaly is one the rare disorders which is usually caused by excess development of growth hormone by the pituitary gland. This excessive growth hormone affects a patient’s internal organs and physical appearance. Acromegaly is mainly caused by benign pituitary tumor (adenoma); however, in rare cases acromegaly is caused by ineffective control of GH-secreting cells by hypothalamus. If acromegaly is untreated or not treated properly, it can lead to serious and life threating complication such as ventricular arrythmia and cardiomyopathy. To detect acromegaly doctor’s use diagnostic approaches such as blood test to measure the level of insulin-like growth factor or growth hormones and imaging of tumor through computed tomography (CT) scan and magnetic resonance image (MRI) scan. In acromegaly treatment some of the medications which are used are 90% effective in shrinking the tumor. However, the success rate for acromegaly treatment varies health, age, and medical history of the patient.

For More Information:  https://growthmarketreports.com/enquiry-before-buying/17

As per GMR industry analyst Vidya Jadhav, “The Global Acromegaly Treatment Market is anticipated to witness significant growth during forecast period 2021-2027 driven by increasing prevalence and incidence of acromegaly across globe, rising awareness across developing economies, increasing initiatives taken by government to promote the awareness about this rear disease. Moreover, the increasing R&D, investments, and boom in clinical trials to develop new medication for acromegaly is expected to create lucrative opportunity during forecast period.”

Key Takeaways from the Study:

Buy Full Report at  https://growthmarketreports.com/press-release/global-acromegaly-treatment-market

Report Scope:

Report Metric

Details

Market Value in 2019

USD 1,304.4 Million

Market Growth Rate (from 2021 to 2027)

7.6 %

Historical Data

2017 & 2018

Base Year

2019

Forecast Period

2020 – 2027

Units Considered

Value (USD Million)

Market Segments

By Product, By End-users

Regional Scope

North America, Europe, Latin America, Asia Pacific, Middle East & Africa (MEA)

Country Scope

U.S., Canada, Brazil, Mexico, Rest of Latin America, China, Japan, South Korea, India, Australia, Southeast Asia, Rest of Asia Pacific, Germany, France, Italy, U.K., Spain, Russia, Rest of Europe, Saudi Arabia, South Africa, UAE, and Rest of MEA.

Key Companies Profiled

Novartis AG, Sun Pharmaceutical Industries Ltd., DAEWOONG PHARMACEUTICAL CO.,LTD., Ispen Pharma, Pfizer Inc., Dauntless Pharmaceuticals, and WOCKHARDT

Pipeline Analysis (Companies Profiled)

Chiasma Inc., Enesi, Peptron, Strongbridge Biopharma plc, Ionis Pharmaceuticals, Inc., Aquestive Therapeutics, Inc., Amryt Pharma plc, and Foresee Pharmaceuticals Co., Ltd.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements.

Target Audience:

Request a free sample copy: https://growthmarketreports.com/request-sample/17

About Us:
Our reports are more than just research reports to us. They are tools that enable us to maintain long-term relationships with our clients whom we honor and cherish. Our client’s business growth is integral for not only them but also us. This is what differentiates us from other market research companies.

At GMR, we provide our expertise and guideline for success. Our team of efficient and experienced researchers and consultants provide progressive market intelligence reports that are accurate, authentic, and in-depth. This empowers the clients to make well-informed decisions.

Moreover, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries including chemicals and materials, energy, automobile, healthcare, consumer goods, and technology. Our deep understanding of many business environments across industries such as those mentioned above allows us to deliver tailor-made reports.



Contact Information:

Contact Us:
Alex Mathews
Head of Business Development
Phone No.: +1 909 545 6473
Email - sales@GrowthMarketReports.com
Website - https://GrowthMarketReports.com
Address - 500 East E Street, Ontario, CA 91764, United States.






Keywords:    Acromegaly Treatment Market, Acromegaly Treatment Market analysis, Acromegaly Treatment Market forecast, Acromegaly Treatment Market players, Acromegaly Treatment Market scope, Acromegaly Treatment Market share, Acromegaly Treatment Market size, Acromegaly Treatment Market trends

Tags:    Reportedtimes, iCN Internal Distribution, Research Newswire, English